Status: current, Defined. Date: 31-May 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4813311000168113 | delta-9-tetrahydrocannabinol 50 mg / 1 mL oral oil, 30 mL (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4813321000168118 | delta-9-tetrahydrocannabinol 50 mg/mL oral oil, 30 mL | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| delta-9-tetrahydrocannabinol 50 mg/mL oral oil, 30 mL | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| delta-9-tetrahydrocannabinol 50 mg/mL oral oil, 30 mL | has MPUU | delta-9-tetrahydrocannabinol 50 mg/mL oral oil | true | Inferred relationship | Some | 1803535010 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cannatrek T50 Ruby THC 50 mg/mL oral oil, 30 mL | Is a | True | delta-9-tetrahydrocannabinol 50 mg/mL oral oil, 30 mL | Inferred relationship | Some | |
| Cannatrek T50 Topaz THC 50 mg/mL oral oil, 30 mL | Is a | True | delta-9-tetrahydrocannabinol 50 mg/mL oral oil, 30 mL | Inferred relationship | Some |
Reference Sets
Schedule 8 medications reference set
Medicinal product pack reference set
FHIR